EXIMIAS PHARMACEUTICAL CORPORATION
Eximias Pharmaceutical Corporation is a healthcare and pharmaceutical company. It focuses on the acquisition, development, and commercialization of unique oncology and infectious disease products. The company has three novel, late-stage products, THYMITAQ(R) and ORATAQ(TM) for oncology, and MACROTAC(TM) for oncology and infectious disease. THYMITAQ(R), the company's flagship product, is being evaluated in a Phase III ETHECC(C) trial for the treatment of patients with unresectable liver cancer. Eximias Pharmaceutical Corporation was founded in 1997. The company was founded by YM BioSciences on April 1, 2006.
EXIMIAS PHARMACEUTICAL CORPORATION
Industry:
Biotechnology Health Care Medical
Founded:
1997-01-01
Address:
Berwyn, Pennsylvania, United States
Country:
United States
Total Employee:
1+
Status:
Active
Total Funding:
0
Current Employees Featured
Investors List
Birchmere Ventures
Birchmere Ventures investment in Seed Round - Eximias Pharmaceutical Corporation
More informations about "Eximias Pharmaceutical Corporation"
YM BioSciences Completes Acquisition Of EXIMIAS Pharmaceutical …
May 10, 2006 Mr. Updike brings over 17 years experience in the areas of business development, sales and marketing. Prior to Eximias, Mr. Updike was a Senior Director of Global Business …See details»
Eximias Pharmaceutical Corp - Company Profile and News
Company profile page for Eximias Pharmaceutical Corp including stock price, company news, executives, board members, and contact informationSee details»
Eximias Pharmaceutical - Company Profile - Tracxn
Jul 20, 2024 Eximias Pharmaceutical (formerly called Zarix) was a late-stage company focussed on the acquisition, development and commercialization of unique oncology and infectious …See details»
Eximias - Products, Competitors, Financials, Employees, …
The company specializes in the development of peptide drugs derived from bodily proteins, known for their anti-aging properties and ability to maintain homeostasis and skin regeneration. …See details»
Eximias Pharmaceutical Corporation acquired by YM BioSciences
Apr 1, 2006 Eximias Pharmaceutical Corporation Eximias Pharmaceutical Corporation is a Health Care company. Acquiring Organization: YM BioSciences YM BioSciences is a life …See details»
EXIMIAS Pharmaceutical Corporation - VentureRadar
EXIMIAS Pharmaceutical Corporation VentureRadar profile. Find out more about EXIMIAS Pharmaceutical Corporation including the VentureRadar Innovation and Growth scores, …See details»
YM BioSciences To Acquire EXIMIAS Pharmaceutical Corporation
Apr 14, 2006 CONTACT: David Allan, CEO, YM BioSciences Inc., Tel: (905) 629-9761; GailSchulze, President and CEO, Eximias Pharmaceutical Corporation, Tel: (610)560-0665See details»
Eximias Pharmaceutical Corporation - Updates, News, Events, …
Apr 1, 2006 Eximias Pharmaceutical Corporation is a Health Care company.See details»
Eximias Pharmaceutical Corp. - BioCentury Company Profiles - BCIQ
Oct 1, 2007 Eximias Pharmaceutical Corp. - BioCentury Company Profiles for the biopharma industrySee details»
EXIMIAS Pharmaceutical - Products, Competitors, Financials, …
EXIMIAS Pharmaceutical is a Berwyn, Pennsylvania-based Healthcare company. Use the CB Insights Platform to explore EXIMIAS Pharmaceutical's full profile. EXIMIAS Pharmaceutical - …See details»
Elizabeth Corsi – Eximias Pharmaceutical Corporation
Oct 14, 2002 ELIZABETH A. CORSI, President, Chief Executive Officer and Director of EXIMIAS Pharmaceutical Corporation, has spent over 17 years in multinational …See details»
EXIMIAS Pharmaceutical Stock Price, Funding, Valuation, Revenue ...
See EXIMIAS Pharmaceutical funding rounds, investors, investments, exits and more. Evaluate their financials based on EXIMIAS Pharmaceutical's post-money valuation and revenue.See details»
Eximias Pharmaceutical Corporation - Crunchbase
Organization. Eximias Pharmaceutical Corporation . Connect to CRM . Save . Summary. Financials. People. Signals & News. Similar Companies. Similar Companies. Edit Similar …See details»
Virginia SCC - Office of the Clerk - Business Lookup via Clerk's ...
Clerk's Information System. The Clerk's Information System (CIS) contains information on file in the Clerk’s Office for Virginia and foreign corporations, limited liability companies, general and …See details»
Coherus Announces Agreement to Divest UDENYCA® Franchise …
20 hours ago REDWOOD CITY, Calif., Dec. 03, 2024 (GLOBE NEWSWIRE) -- Coherus BioSciences, Inc. (Coherus or the Company NASDAQ: CHRS,) today announced that it has …See details»
Chiesi Group and Apotex Inc. finalize agreement for acquisition of ...
Chiesi employs over 5,600 people. Chiesi Group is a certified Benefit corporation. For more information, please visit www.chiesi.com. About Apotex Inc. Apotex Inc. is a proudly Canadian, …See details»
Actinium Pharmaceuticals, Inc. Announces Greater Difference of ...
NEW YORK, Dec. 13, 2021 /PRNewswire/ -- Actinium Pharmaceuticals, Inc. (NYSE AMERICAN: ATNM) ("Actinium" or the "Company"), a leader in the development of targeted radiotherapies …See details»
Home | GSK US
GSK US is a leading biopharmaceutical company focusing on vaccines, specialty medicines, and respiratory care.See details»
Eximias Pharmaceutical Corporation - Funding, Financials, …
Apr 1, 2004 Eximias Pharmaceutical Corporation has raised 1 round. This was a Seed round raised on Apr 1, 2004 . Eximias Pharmaceutical Corporation is funded by Birchmere Ventures .See details»
Arrowhead Pharmaceuticals Reports 2024 Fiscal Year-End Results
Sep 30, 2024 Arrowhead Pharmaceuticals, Inc. today announced financial results for its 2024 fiscal year ended September 30, 2024. The Company is hosting a conference call today, …See details»